Venous Thromboembolic Disease Clinical Trial
Official title:
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
The occurrence of VTE in hospital is an important cause of unexpected death of inpatients, and has become a serious problem faced by hospital managers and clinical medical staff.Under the target of "Improving the Standard Prevention Rate of Venous Thromboembolism" proposed in the "National Medical Quality and Safety Improvement Goal in 2022", it is urgent to establish a highly sensitive VTE risk assessment and monitoring system.At present, VTE risk assessment scale is used for risk screening and monitoring in combination with D-dimer in clinical practice, but D-dimer has low specificity and poor sensitivity, which makes it impossible to accurately assess the risk of venous thrombosis.Therefore, it is very important to explore highly specific molecular markers of thrombosis for VTE risk assessment.This project will analyze the value of single or combined detection of different thrombus molecular markers in VTE risk assessment, establish the best VTE risk assessment scheme, improve the standardized prevention of VTE, realize the early intervention of VTE, truly achieve early detection, early prevention and early treatment, and effectively reduce the occurrence of VTE.
This project is intended to explore the specificity and reliability of single or combined detection of different thrombus molecular markers in venous thrombosis risk assessment by detecting and analyzing the levels of various thrombus molecular markers in VTE high-risk patients, so as to establish the best evaluation strategy for early identification of VTE high-risk patients, build the hospital VTE early warning management system, guide the clinical to formulate targeted graded intervention measures, and effectively reduce the occurrence of VTE. At the same time, it will provide support for the realization of "improving the standard prevention rate of venous thromboembolism" proposed in the national medical quality and safety improvement goal in 2022 and reducing medical risks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04414332 -
Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
|
||
| Recruiting |
NCT03206372 -
Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
|
||
| Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
| Not yet recruiting |
NCT02188056 -
Observational Prospectif Monocentric Registry of Patients Suffering From VIE
|
N/A | |
| Completed |
NCT04846725 -
Predictors of Attempted Inferior Vena Cava Filters Retrieval.
|
||
| Completed |
NCT01729559 -
Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
|
Phase 4 | |
| Completed |
NCT01466426 -
The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)
|
N/A | |
| Recruiting |
NCT05150314 -
Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
|
||
| Active, not recruiting |
NCT05396157 -
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
|
||
| Active, not recruiting |
NCT00691470 -
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
|
Phase 2/Phase 3 | |
| Completed |
NCT04824118 -
Clotting Parameters After Medical Abortion
|
||
| Recruiting |
NCT03887806 -
Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study
|
||
| Not yet recruiting |
NCT06232551 -
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
|
N/A | |
| Recruiting |
NCT05993533 -
Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy
|
||
| Recruiting |
NCT04211181 -
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
|
N/A | |
| Completed |
NCT04818151 -
Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
|
||
| Recruiting |
NCT05089227 -
Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study
|
Phase 2 | |
| Completed |
NCT03894878 -
Association Between Genetic Variant Scores and Warfarin Effect
|
||
| Completed |
NCT00556426 -
Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.
|
N/A | |
| Not yet recruiting |
NCT04158973 -
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
|
N/A |